This summer, a new targeted treatment for pancreatic cancer was approved by the FDA. The treatment, Rasonque (daraxonrasib), is giving new hope to people with a disease that had been seen as almost untreatable. In this episode, Chuck and Alicia unpack this new development with Dr. Brian Wolpin, director of the Hale Family Center for Pancreatic Cancer Research at Dana-Farber Cancer Institute, who led the drug trial.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Charles Ryan MD, Alicia Morgans MD MPH. Innehållet i podden är skapat av Charles Ryan MD, Alicia Morgans MD MPH och inte av, eller tillsammans med, Poddtoppen.